Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge-Reference-Cited by-同舟云学术

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge

Published:2015-05-20 Issue:7 Volume:64 Page:893-902
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

de Witte Moniek A.,Kierkels Guido J. J.,Straetemans Trudy,Britten Cedrik M.,Kuball Jürgen

Funder

Netherlands Organisation for Health Research and Development

WorldWideCancerResearch

KWF Kankerbestrijding

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-015-1710-8/fulltext.html

Reference49 articles.

1. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S et al (2000) Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 343:750–758

2. Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12:269–281

3. Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A et al (2014) Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 371:2189–2199

4. Robert C, Thomas L, Bondarenko I, O’Day S, Weber J, Garbe C et al (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364:2517–2526

5. R. E. Hawkins, D. E. Gilham, R. Debets, Z. Eshhar, N. Taylor, H. Abken, T. N. Schumacher, and ATTACK Consortium (2010) Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther 21:665–672

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR‐T cell therapeutic avenue for fighting cardiac fibrosis: Roadblocks and perspectives;Cell Biochemistry and Function;2024-02-20

2. A Winning New Combination? Toward Clinical Application in Oncology;Cancer Control;2023-04

3. Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells;Molecular Therapy - Methods & Clinical Development;2021-09

4. Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies;Nature Reviews Drug Discovery;2019-09-06

5. Precision oncology: myth or reality?;TARGETED ONCOTHERAPY;2019-03-31